Competition will make weight-loss drugs better, cheaper and bigger
23 hours ago

Competition will make weight-loss drugs better, cheaper and bigger

Live Mint  

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Patrik Jonsson, head of the division at Eli Lilly that is responsible for weight-loss drugs, says that the level of competition is something he has never experienced before. In China nearly half of all adults are overweight or obese, making it a huge potential market for weight-loss drugs. Eli Lilly and Innovent, a Chinese biotech firm, are developing a drug for the market called Mazdutide that is expected to be available from next year at around half the price of Zepbound in America.

India Weight Loss China Market Drugs Developing Drug Novo Nordisk Wegovy Zepbound Eli Lilly Lilly Eli  developing  weightloss  lilly  eli  market  patients  drugs  firm  competition  expected  better  bigger  cheaper  drug

History of this topic

Biden proposes huge expansion of weight loss drug access
4 weeks ago

Biden proposes huge expansion of weight loss drug access

Raw Story  

by Danny KEMP Outgoing U.S. President Joe Biden proposed Tuesday to give millions more Americans access to weight loss drugs -- but Donald Trump's incoming health chief looked set to shoot down the idea. Any plan to increase US public health insurance spending would also likely run foul of Trump's bid to slash government budgets and waste. Trump said last …

Column: The Ozempic revolution in weight-loss drugs exposes the weakest links in our healthcare system — drug pricing and insurance
3 months, 4 weeks ago

Column: The Ozempic revolution in weight-loss drugs exposes the weakest links in our healthcare system — drug pricing and insurance

LA Times  

The diabetes and weight-loss drug Ozempic. This limits the length of time that health gains can be internalized as reduced claims.’ — David Anderson, University of South Carolina health policy expert Yet millions of Americans are unable to access these drugs, thanks to the two big, interrelated flaws in our healthcare system: unrestrained pricing by drug companies and the economics …

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?
5 months, 1 week ago

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?

Firstpost  

Eli Lilly, the pharmaceutical company, has received the first approval for the sale of its blockbuster drug Tirzepatide in India. Here’s what we know about this ‘game-changing’ medication A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah. Last week, the apex drug regulator’s, …

Wegovy weight-loss drug OK'd in China
5 months, 4 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

By AI HEPING in New York | chinadaily.com.cn | Updated: 2024-06-26 14:54 FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and …

Do weight loss drugs work for diet industry built on eating less and exercising more?
7 months, 3 weeks ago

Do weight loss drugs work for diet industry built on eating less and exercising more?

Hindustan Times  

Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. Do weight loss drugs work for diet industry built on eating less and exercising more? He's lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial …

Why weight-loss drugs will reshape the world
8 months, 1 week ago

Why weight-loss drugs will reshape the world

The Economist  

Listen to this podcast Your browser does not support the <audio> element. Both make the “miracle” drugs that can help people shed up to a fifth of their body weight. Guests: The Economist’s Georgia Banjo; pharmaceuticals analyst Michael Nedelcovych; and John Cawley, a professor of public policy and economics at Cornell University. Subscribers to Economist Podcasts+ can listen to our …

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group
1 year, 1 month ago

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group

Daily Mail  

AstraZeneca has entered the race to develop a weight-loss drug after striking a £1.6billion deal with a Chinese medical group. China deal: AstraZeneca boss Pascal Soriot said that the move into weight loss drugs follows 'enormous need around the world' Details emerged just hours after it was revealed that AstraZeneca is facing a multi-million-pound legal battle over claims the efficacy …

Supply problems and insurance issues make popular weight-loss drugs hard to get
1 year, 3 months ago

Supply problems and insurance issues make popular weight-loss drugs hard to get

Associated Press  

When she prescribes the popular weight-loss drug Wegovy, Dr. Angela Fitch sends patients on a quest she likens to “The Hunger Games.” They will have to call drugstores over several days to find one with the properly sized first dose. Supply problems and insurance complications have made it difficult for people to start — and stay on — Wegovy and …

Maker of fat-loss drugs Wegovy and Ozempic says shortages will be fixed in weeks
1 year, 10 months ago

Maker of fat-loss drugs Wegovy and Ozempic says shortages will be fixed in weeks

Daily Mail  

The maker of pharmaceutical blockbuster Wegovy for weight loss expects shortages to be resolved in the next few months as it ramps up production. An increase in demand combined with manufacturing hiccups caused a contraction in the supply chain last year, leaving behind a shortage of both Wegovy and its sister drug Ozempic. There has been such high demand that …

Discover Related